Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 8,509-8,520 of 23,847
Drug study icon
CompletedNCT00132678

Safety study of safety and Efficacy of Injectable Risperidone in Bipolarity

This study is completed in the United States, in Austria, in India, .... It is testing safety and Efficacy of Injectable Risperidone for Bipolarity.

Multiple locations, including Little Rock
BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Austria, India, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Bipolarity
Drug study icon
CompletedNCT00477672

Safety study of safety and Efficacy of Pimavanserin in Schizophrenia

This study is completed in the United States, in France, in the United Kingdom, .... It is testing safety and Efficacy of Pimavanserin for Schizophrenia.

Multiple locations, including Gilbert
SchizophreniaDrugOver 40 Years
Countries
United States, France, United Kingdom, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT04479852

Safety and Efficacy of SP-624 for depression

This study is completed in the United States. It is testing Safety and Efficacy of SP-624 for depression.

Multiple locations, including Phoenix
DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Sirtsei Pharmaceuticals, Inc.
Condition
Depression
Drug study icon
CompletedNCT00650611

Safety study of ziprasidone in Schizophrenia

This study is completed in the United States. It is testing ziprasidone for Schizophrenia.

Multiple locations, including San Diego
Schizophrenia, BipolarityDrugFrom 10 Years to 17 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT00550238

Safety study of pimavanserin in Schizophrenia

This study is completed in the United States, in France, in Canada, .... It is testing pimavanserin for Schizophrenia.

Multiple locations, including Gilbert
SchizophreniaDrugOver 40 Years
Countries
United States, France, Canada, ...
Sponsor
ACADIA Pharmaceuticals Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.